Natural history of hepatitis C virus infection: From chronic hepatitis to cirrhosis, to hepatocellular carcinoma;Storia naturale dell'infezione da virus dell'epatite C: Dall'epatite cronica, alla cirrosi, al carcinoma epatocellulare

Minerva Gastroenterologica e Dietologica

Volumn 51, Issue 1, 2005, Pages 31-46

  Leone, N ^a   Rizzetto, M ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

Chronic hepatitis; Hepatitis C infection; Hepatocellular carcinoma; Liver cirrhosis; Liver transplantation; Natural history

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

ACUTE HEPATITIS; ALCOHOL CONSUMPTION; ARTICLE; CELLULAR IMMUNITY; CHRONIC HEPATITIS; DISEASE COURSE; FATTY LIVER; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER INJURY; LIVER TRANSPLANTATION; MORBIDITY; MORTALITY; VIRUS INFECTION; VIRUS LOAD; ADULT; AIDS RELATED COMPLEX; COMPARATIVE STUDY; ENZYME ASSAY; FEMALE; FOLLOW UP; GENETICS; HEPATITIS C VIRUS; IMMUNE DEFICIENCY; IMMUNOLOGY; LIVER TUMOR; MALE; TIME;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; ENZYME TESTS; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; IMMUNOCOMPROMISED HOST; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; RNA, VIRAL; TIME FACTORS; VIRAL LOAD;

EID: 19444372156     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Amarapurkar D. Natural history of hepatitis C virus infection. J Gastroenterol Hepatol 2000;15:E105-10.
2. Benvegnù L, Noventa F, Bernardinello E, Pontisso P, Gatta A, Alberti A. Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development. Gut 2001;48:110-5.
3. Fernandez-Rodriguez CM, Gutierrez ML, Serrano PL, Lledo JL, Santander C, Fernandez TP et al. Factors influencing the rate of fibrosis progression in chronic hepatitis C. Dig Dis Sci 2004;49:1971-6.
4. Lagging LM, Westin J, Svensson E, Aires N, Dhillon AP, Lindh M et al. Progression of fibrosis in untreated patients with hepatitis C virus infection. Liver 2002;22:136-44.
5. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24:289-93.
6. Koziel MJ, Wong DK, Dudley D, Houghton M, Walker BD. Hepatitis C virus specific cytolytic T lymphocytes and T helper responses in seronegative persons. J Infect Dis 1997;176:859-66.
7. Scognamiglio P, Accapezzato D, Casciaro MA, Caccaini A, Artini M, Bruno G et al. Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy sieronegative donors. J Immunol 1999;162:6681-9.
8. Tremolada F, Casarin C, Alberti A, Drago C, Tagger A, Ribero ML et al. Long-term follow-up of NANB (type C) post-trasfusion hepatitis. J Hepatol 1992;16:273-81.
9. Alberti A, Chemello L, Benvegnù L. Natural history of hepatitis C. J Hepatol 1999;31:17-24.
10. Gerlach JT, Diepolder HM, Gruner NH. Natural course of symptomatic acute hepatitis C. J Hepatol 1999;30:120-1.
11. Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL et al. Long term mortality after transfusion associated NANB hepatitis. N Engl J Med 1992;327:1906-11.
12. Seeff LB, Hollinger B, Alter AJ. Long-term of morbidity of post-transfusion of hepatitis C. Hepatology 1998;28:407A.
13. Pagliaro L, Peri V, Linea C, Camma C, Giunta M, Magrin S. Natural history of chronic hepatitis C: a systematic review. Ital J Gastroenterol Hepatol 1999;31:28-44.
14. Barrera JM, Bruguera M, Ercilla MG, Gil C, Celis R, Gil MP et al. Persistent hepatitis C viremia after acute self-limiting post-transfusion hepatitis C. Hepatology 1995;21:639-44.
15. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic PT hepatitis. Hepatology 1991;14:969-74.
16. Korezt RL, Abbey H, Coleman E, Gitnich G. Non-A, non-B post-transfusion hepatitis -looking back in the second decade. Ann Intern Med 1993;119:110-5.
17. Ryder SD, Irving WL, Jones DA, Neal KR, Underwood JC; Trent Hepatitis C Study Group. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut 2004;53:451-5.
18. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 2001;34:730-90
19. Alberti A, Benvegnù L, Boccato S, Ferrari A, Sebastriani G. Natural history of initially mild chronic hepatitis C. Dig Liver Dis 2004;36:645-54.
20. FASL International Consensus Conference on hepatitis C. Paris 26-27 February 1999. Consensus statement. J Hepatol 1999;31:3-8.
21. NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens State Sci Statements 2002;19: 1-46.
22. Poynard T, Bedossa P, Opolon P. Natural history of fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-32.
23. Chemello L, Cavalletto L, Bernardinello K. Biochemical and histological activity predicts liver fibrosis progression in chronic hepatitis C. J Hepatol 1999;31:17-24.
24. Vaquer P, Canet R, Llompart A, Riera J, Obrador A, Gayà J. Histological evolution of chronic hepatitis C. Factors related to progression. Liver 1994;14:265-9.
25. Mattson L, Sonnenborg A, Weiland O. Outcome of acute symptomatic non-A, non-B hepatitis: a 13-year follow-up study of hepatitis C virus markers. Liver 1993;13:274-8.
26. Kao JH, Tsai SL, Chen PJ, Yang PM, Sheu JC, Lai MY et al. A clinicopathologic study of chronic non-A, non-B (type C) hepatitis in Taiwan. Comparison between post-transfusion and sporadic patients. J Hepatol 1994;21:244-9.
27. Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 1995;21:650-5.
28. Wejstal R, Hermodsson S, Norkrons G. Long-term follow-up of chronic hepatitis NANB with special reference to hepatitis C. Liver 1991;11:143-8.
29. Hopf U, Moller B, Kuther D, Stemerowicz R, Lobeck H, Ludtke-Handjery A et al. Long-term follow-up of post-transfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatol 1990;10:69-76.
30. Yousuf M, Nakano Y, Tanaka F, Sodeyama T, Kiyosawa K. Persistence of viremia in patients with type-C chronic hepatitis during long-term follow-up. Scand J Gastroenterol 1992;27:812-6.
31. Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inowe O et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996;23:1334-40.
32. Sanchez-Tapias JM, Lo Iacono O. Storia naturale dell 'infezione cronica da HCV: dall'epatite cronica alla cirrosi. In: Craxì A, Almasio P, Magrin S editors. Il virus dell'epatite C (HCV): l'infezione e la malattia. Milano: Roche; 1995. Vol. 2. p. 11-25.
33. Kobayashi M, Tanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K. The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 1996;23:695-9.
34. Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol 1993;88:240-3.
35. Shev S, Dhillon AP, Lindh M, Serèus Z, Wejstal R, Widell A et al. The importance of cofactors in the histological progression of minimal and mild chronic hepatitis C. Liver 1997;17:215-33.
36. Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P et al. Morbidity and mortalità in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997;112:463-72.
37. Serfaty L, Aumaitre H, Chazouilleres O, Bonnand AM, Rosmorduc O, Poupon RE et al. Determinants of outcomer of compensated hepatitis C virus related cirrhosis. Hepatology 1998;27:1435-40.
38. Hu KQ, Tong MJ. The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States. Hepatology 1999;29:1311-6.
39. Benvegnù L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 1994;74:2442-8.
40. Yu MW, Chang HC, Chang SC, Liaw YF, Lin SM, Liu CJ et al. Role of reproductive factors in hepatocellular carcinoma: impact on hepatitis B- and C-related risk. Hepatology 2003;38:1393-400.
41. Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P, Buendia MA. Altered expression of E-cadherin in hepatocellular carcinoma: correlation with genetic alterations, beta-catenin expression, and clinical features. Hepatology 2002;36:692-701.
42. Benvegnù L, Gios M, Boccato S, Alberti A. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut 2004;53:744-9.